Pro Medicus stock keeps its valuation in focus

Published on 09/22/2026 at 21:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pro Medicus stock carried a A$17.3 billion market value on September 22, 2026. Operations generated about A$261.7 million, while software remains central.

Pro Medicus, AU000000PME8, Illustration mit AI erstellt.

Pro Medicus stock, identified by ISIN AU000000PME8, carried a market capitalization of A$17.3 billion on September 22, 2026. The company operates medical imaging software platforms including Visage 7 and Visage RIS/PACS for hospitals and imaging centers.

Valuation meets software growth

According to Simply Wall St on September 22, 2026, Pro Medicus generated about A$261.7 million from integrated healthcare imaging software. The same dated company overview put its market value at A$17.3 billion, making the valuation roughly 66 times that operating figure.

That comparison is the key investor calculation in the available data: the market value is much larger than one year's cited operating revenue figure. The business serves customers across Australia, North America and Europe, so contract execution and recurring software demand remain material to the valuation.

Visage platforms drive the case

Pro Medicus provides Visage 7 and Visage RIS/PACS, software products that support radiology workflows in hospitals and imaging centers. The September 22, 2026 overview describes the group as founder-led and identifies integrated healthcare imaging software as its operating base.

The cited A$261.7 million figure is a concrete revenue measure for the business description, while the A$17.3 billion market capitalization is a market measure from the same dated source. Together, the figures show why operational growth must continue to justify the company's equity value, without implying a price forecast.

Market value remains the checkpoint

As of September 22, 2026, Pro Medicus had a reported market capitalization of A$17.3 billion. The company's reference listing is the Australian Securities Exchange under ticker PME, and its sector is healthcare technology with a medical imaging software focus.